• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3-和 4-甲基对 N-取代反式 3,4-二甲基-4-(3-羟基苯基)哌啶类阿片受体性质的影响。

Effect of the 3- and 4-methyl groups on the opioid receptor properties of N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines.

机构信息

Center for Organic and Medicinal Chemistry, Research Triangle Institute , P.O. Box 12194, Research Triangle Park, North Carolina 27709, United States.

出版信息

J Med Chem. 2014 Apr 10;57(7):3140-7. doi: 10.1021/jm500184j. Epub 2014 Mar 26.

DOI:10.1021/jm500184j
PMID:24635568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4070716/
Abstract

N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines (2a,b) are opioid receptor antagonists where the antagonist properties are not due to the type of N-substituent. In order to gain a better understanding of the contribution that the 3- and 4-methyl groups make to the pure antagonist properties of 2a,b, we synthesized analogues of 2a,b that lacked the 4-methyl (5a,b), 3-methyl (6a,b), and both the 3- and 4-methyl group (7a,b) and compared their opioid receptor properties. We found that (1) all N-methyl and N-phenylpropyl substituted compounds were nonselective opioid antagonists (2) all N-phenylpropyl analogues were more potent than their N-methyl counterparts, and (3) compounds 2a,b which have both a 3- and 4-methyl substituent, were more potent antagonists than analogues 5a,b, 6a,b, and 7a,b. We also found that the removal of 3-methyl substituent of N-methyl and N-phenylpropyl 3-methyl-4-(3-hydroxyphenyl)piperazines (8a,b) gives (4a,b), which are opioid antagonists.

摘要

N-取代的反式 3,4-二甲基-4-(3-羟基苯基)哌啶(2a,b)是阿片受体拮抗剂,其拮抗剂性质不是由于 N-取代基的类型。为了更好地了解 3-和 4-甲基对 2a,b 的纯拮抗剂性质的贡献,我们合成了缺乏 4-甲基(5a,b)、3-甲基(6a,b)和 3-和 4-甲基(7a,b)的 2a,b 的类似物,并比较了它们的阿片受体性质。我们发现:(1)所有 N-甲基和 N-丙基取代的化合物都是非选择性阿片受体拮抗剂;(2)所有 N-丙基类似物都比其 N-甲基类似物更有效;(3)具有 3-和 4-甲基取代基的化合物 2a,b 比类似物 5a,b、6a,b 和 7a,b 更有效。我们还发现,N-甲基和 N-丙基 3-甲基-4-(3-羟基苯基)哌嗪(8a,b)中 3-甲基取代基的去除会产生(4a,b),它是阿片受体拮抗剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2552/4203405/b2338de3eb44/jm-2014-00184j_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2552/4203405/a6d5540f0457/jm-2014-00184j_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2552/4203405/91d6fe1f7732/jm-2014-00184j_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2552/4203405/0ee1544a6583/jm-2014-00184j_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2552/4203405/d3bb7f7bd8ac/jm-2014-00184j_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2552/4203405/b2338de3eb44/jm-2014-00184j_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2552/4203405/a6d5540f0457/jm-2014-00184j_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2552/4203405/91d6fe1f7732/jm-2014-00184j_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2552/4203405/0ee1544a6583/jm-2014-00184j_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2552/4203405/d3bb7f7bd8ac/jm-2014-00184j_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2552/4203405/b2338de3eb44/jm-2014-00184j_0006.jpg

相似文献

1
Effect of the 3- and 4-methyl groups on the opioid receptor properties of N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines.3-和 4-甲基对 N-取代反式 3,4-二甲基-4-(3-羟基苯基)哌啶类阿片受体性质的影响。
J Med Chem. 2014 Apr 10;57(7):3140-7. doi: 10.1021/jm500184j. Epub 2014 Mar 26.
2
Synthesis and in vitro opioid receptor functional antagonism of methyl-substituted analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic).(3R)-7-羟基-N-[(1S)-1-{[(3R,4R)-4-(3-羟基苯基)-3,4-二甲基-1-哌啶基]甲基}-2-甲基丙基]-1,2,3,4-四氢-3-异喹啉甲酰胺(JDTic)的甲基取代类似物的合成及体外阿片受体功能拮抗作用
J Med Chem. 2009 Dec 10;52(23):7463-72. doi: 10.1021/jm900756t.
3
Design, Synthesis, and Biological Evaluation of Structurally Rigid Analogues of 4-(3-Hydroxyphenyl)piperidine Opioid Receptor Antagonists.设计、合成及结构刚性类似物的生物评价 4-(3-羟基苯基)哌啶类阿片受体拮抗剂。
J Org Chem. 2016 Nov 4;81(21):10383-10391. doi: 10.1021/acs.joc.6b01366. Epub 2016 Aug 2.
4
N-substituted cis-4a-(3-hydroxyphenyl)-8a-methyloctahydroisoquinolines are opioid receptor pure antagonists.N-取代的顺式-4a-(3-羟基苯基)-8a-甲基八氢异喹啉类化合物是阿片受体纯拮抗剂。
J Med Chem. 2005 Dec 29;48(26):8182-93. doi: 10.1021/jm058261c.
5
Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.鉴定用于(+)-(3R,4R)-二甲基-4-(3-羟基苯基)哌啶的阿片κ受体亚型选择性N-取代基。
J Med Chem. 1998 Dec 17;41(26):5188-97. doi: 10.1021/jm980511k.
6
N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonists.N-取代八氢-4a-(3-羟基苯基)-10a-甲基苯并[g]异喹啉类是阿片受体纯拮抗剂。
Bioorg Med Chem Lett. 1998 Nov 17;8(22):3149-52. doi: 10.1016/s0960-894x(98)00576-9.
7
Analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic). Synthesis and in vitro and in vivo opioid receptor antagonist activity.(3R)-7-羟基-N-[(1S)-1-{(3R,4R)-4-(3-羟基苯基)-3,4-二甲基-1-哌啶基甲基}-2-甲基丙基]-1,2,3,4-四氢-3-异喹啉甲酰胺(JDTic)类似物。合成及体外和体内阿片受体拮抗剂活性。
J Med Chem. 2010 Jul 22;53(14):5290-301. doi: 10.1021/jm1004978.
8
Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.N-取代反式-3,4-二甲基-4-(3-羟基苯基)哌啶类μ-阿片受体拮抗剂生物活性构象的阐明。
J Med Chem. 2006 Dec 14;49(25):7278-89. doi: 10.1021/jm060486f.
9
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists.关于(+)-(3R, 4R)-二甲基-4-(3-羟基苯基)哌啶类阿片拮抗剂中N-取代基构象对效力和μ受体亚型选择性影响的研究
J Med Chem. 1998 May 21;41(11):1980-90. doi: 10.1021/jm980063g.
10
The discovery and development of the N-substituted trans-3,4-dimethyl-4-(3'-hydroxyphenyl)piperidine class of pure opioid receptor antagonists.N-取代反式-3,4-二甲基-4-(3'-羟基苯基)哌啶类纯阿片受体拮抗剂的发现与开发。
ChemMedChem. 2014 Aug;9(8):1638-54. doi: 10.1002/cmdc.201402142. Epub 2014 Jun 30.

引用本文的文献

1
N-(3-Hydroxyphenyl)-3,8-diazabicyclooctanes as opioid receptors probes. 1. Investigation of the phenolic hydroxyl group.N-(3-羟基苯基)-3,8-二氮杂双环辛烷作为阿片受体探针。1. 酚羟基的研究。
Eur J Med Chem. 2025 Nov 15;298:117991. doi: 10.1016/j.ejmech.2025.117991. Epub 2025 Jul 23.
2
Searching for Synthetic Opioid Rescue Agents: Identification of a Potent Opioid Agonist with Reduced Respiratory Depression.寻找合成阿片类药物解毒剂:发现一种具有降低呼吸抑制作用的强效阿片类激动剂。
J Med Chem. 2024 Jun 13;67(11):9173-9193. doi: 10.1021/acs.jmedchem.4c00333. Epub 2024 May 29.
3
Design, Synthesis, and Biological Evaluation of Structurally Rigid Analogues of 4-(3-Hydroxyphenyl)piperidine Opioid Receptor Antagonists.

本文引用的文献

1
1-Substituted 4-(3-Hydroxyphenyl)piperazines Are Pure Opioid Receptor Antagonists.1-取代的4-(3-羟基苯基)哌嗪是纯阿片受体拮抗剂。
ACS Med Chem Lett. 2010 Oct 14;1(7):365-369. doi: 10.1021/ml100126b.
2
Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist.鉴定(3R)-7-羟基-N-((1S)-1-[[(3R,4R)-4-(3-羟基苯基)-3,4-二甲基-1-哌啶基]甲基]-2-甲基丙基)-1,2,3,4-四氢-3-异喹啉甲酰胺为一种新型强效选择性阿片κ受体拮抗剂。
J Med Chem. 2003 Jul 3;46(14):3127-37. doi: 10.1021/jm030094y.
3
设计、合成及结构刚性类似物的生物评价 4-(3-羟基苯基)哌啶类阿片受体拮抗剂。
J Org Chem. 2016 Nov 4;81(21):10383-10391. doi: 10.1021/acs.joc.6b01366. Epub 2016 Aug 2.
4
Design, synthesis, and pharmacological evaluation of JDTic analogs to examine the significance of the 3- and 4-methyl substituents.JDTic类似物的设计、合成及药理评价,以研究3-甲基和4-甲基取代基的重要性。
Bioorg Med Chem. 2015 Oct 1;23(19):6379-88. doi: 10.1016/j.bmc.2015.08.025. Epub 2015 Aug 25.
5
Discovery of the first small-molecule opioid pan antagonist with nanomolar affinity at mu, delta, kappa, and nociceptin opioid receptors.首个对μ、δ、κ和孤啡肽阿片受体具有纳摩尔亲和力的小分子阿片类全拮抗剂的发现。
ACS Chem Neurosci. 2015 Apr 15;6(4):646-57. doi: 10.1021/cn500367b. Epub 2015 Feb 18.
2002 Medicinal Chemistry Division Award address: monoamine transporters and opioid receptors. Targets for addiction therapy.
2002年药物化学分部奖致辞:单胺转运体与阿片受体。成瘾治疗的靶点。
J Med Chem. 2003 May 8;46(10):1775-94. doi: 10.1021/jm030092d.
4
Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity.首个具有高效且选择性阿片κ受体拮抗剂活性的反式-(3R,4R)-二甲基-4-(3-羟基苯基)哌啶衍生物的鉴定。
J Med Chem. 2001 Aug 16;44(17):2687-90. doi: 10.1021/jm015521r.
5
Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.鉴定用于(+)-(3R,4R)-二甲基-4-(3-羟基苯基)哌啶的阿片κ受体亚型选择性N-取代基。
J Med Chem. 1998 Dec 17;41(26):5188-97. doi: 10.1021/jm980511k.
6
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists.关于(+)-(3R, 4R)-二甲基-4-(3-羟基苯基)哌啶类阿片拮抗剂中N-取代基构象对效力和μ受体亚型选择性影响的研究
J Med Chem. 1998 May 21;41(11):1980-90. doi: 10.1021/jm980063g.
7
3,4-Dimethyl-4-(3-hydroxyphenyl)piperidines: opioid antagonists with potent anorectant activity.
J Med Chem. 1993 Oct 1;36(20):2842-50. doi: 10.1021/jm00072a002.
8
Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptors.
J Med Chem. 1993 Oct 1;36(20):2833-41. doi: 10.1021/jm00072a001.
9
Naloxone, naltrexone, and related noroxymorphones.
Adv Biochem Psychopharmacol. 1973;8(0):33-43.
10
Investigation of 4-(3-hydroxyphenyl)-4-methylpipecolic acid as a conformationally restricted mimic of the tyrosyl residue of leucine-enkephalinamide.
J Med Chem. 1986 Oct;29(10):2028-33. doi: 10.1021/jm00160a039.